Thomas Massie actually said...

Biopharmaceutical companies are far outspending the Federal Government for R&D for cures for various diseases.

Policies that incentivize investment in pharmaceutical innovation is a good thing, and that is where we need to be focused.

We just simply cannot go down that path of eliminating any potential cure for some of these serious diseases.

I do wish that my friends on the other side of the aisle, if they were serious about true reform and lowering prices we would be looking at ...